Efficacy Of Drakshadi Gutika and Eladi Gutika In tobacco chewing withdrawal syndrome

A Randomized Comparative Clinical Study To Evaluate The Efficacy Of Drakshadi Gutika and Eladi Gutika In tobacco chewing withdrawal syndrome - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/11/098058

Enrollment

Registered

2025-11-25

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F172- Nicotine dependence

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with FTND-ST score ranging from 5-10 moderate to severe. Patients of either sex Patients willing to give consent for clinical trial. Age between 18-60 years Patient having clinical manifestation of tobacco withdrawal syndrome as per given in table of Minnesota nicotine withdrawal scale.

Exclusion criteria

Exclusion criteria: Patients with any type of psychiatric disorders, neurological disorders like Alzheimer s disease, Parkinsonism, any type of Venereal diseases, any major systemic diseases like Carcinoma, Heart diseases, Hepatic and Renal failure, DM, unmanageable hypertension etc. Patients who are receiving any contemporary de addiction treatment. Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Changes in Score of tobacco chewing withdrawal syndrome on the basis of Minnesota Nicotine Withdrawal Scale will be checked. Timepoint: 21 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactNikita Namdev Nakhate

National Institute of Ayurveda Jaipur

anita31sharma@yahoo.com9414078653

Outcome results